Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Senator Manchin Goes to White Oak

This article was originally published in RPM Report

Executive Summary

The open public hearing portion of an advisory committee is often emotional and sometimes persuasive. It is not usually a forum for a give-and-take with a sitting US Senator. But it was during a two-day review of the DEA scheduling status of hydrocodone combos.


Related Content

Primatene HFA Turned Down By FDA Panel; Will Capitol Hill Accept Decision?
Zogenix Zohydro Launch Will Test FDA’s Balanced Approach On Opioid Pain Reviews
Sen. Burr Tries To Pull FDASIA Over For Speeding As Senate Sends Bill To White House





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts